High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Chen, Hai Tao ^a,b   Cai, Quan Cai ^a,b   Zheng, Jian Ming ^b   Man, Xiao Hua ^b   Jiang, Hui ^b   Song, Bin ^b   Jin, Gang ^b   Zhu, Wei ^a,b   Li, Zhao Shen ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DELTA LIKE LIGAND 4; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION;

ADULT; AGED; AREA UNDER CURVE; CARCINOMA, PANCREATIC DUCTAL; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; LYMPHOCYTE COUNT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEUTROPHILS; PANCREATIC NEOPLASMS; PLATELET COUNT; PROPORTIONAL HAZARDS MODELS; ROC CURVE; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84864991453     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1968-9     Document Type: Article

References (33)

1. Ministry of Health of the People's Republic of China. Mortality rate of 10 main malignant neoplasms from 1973 to 2005. http://www.moh.gov.cn/ publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2009/t-9.htm. Accessed 15 Nov 2010.
2. M Wagner C Redaelli M Lietz CA Seiler H Friess MW Buchler 2004 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg. 91 586 594 15122610 10.1002/bjs.4484 1:STN:280:DC%2BD2c3it1ansA%3D%3D
3. KC Conlon DS Klimstra MF Brennan 1996 Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors Ann Surg 223 273 279 8604907 10.1097/00000658-199603000-00007 1:STN:280:DyaK287pvFSgsQ%3D%3D
4. P Buchler HA Reber MW Buchler H Friess OJ Hines 2002 VEGF-RII influences the prognosis of pancreatic cancer Ann Surg. 236 738 749 12454512 10.1097/00000658-200212000-00006
5. Y Seo H Baba T Fukuda M Takashima K Sugimachi 2000 High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma Cancer. 88 2239 2245 10820344 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID- CNCR6>3.0.CO;2-V 1:CAS:528:DC%2BD3cXjslSqtbo%3D
6. M Niedergethmann R Hildenbrand B Wostbrock M Hartel JW Sturm A Richter, et al. 2002 High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas Pancreas. 25 122 129 12142733 10.1097/00006676-200208000-00002
7. RS Kerbel 2008 Tumor angiogenesis N Engl J Med. 358 2039 2049 18463380 10.1056/NEJMra0706596 1:CAS:528:DC%2BD1cXlsFyrtro%3D
8. RK Jain DG Duda JW Clark JS Loeffler 2006 Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat Clin Pract Oncol. 3 24 40 16407877 10.1038/ncponc0403 1:CAS:528:DC%2BD28XhtVynsL0%3D
9. S Artavanis-Tsakonas MD Rand RJ Lake 1999 Notch signalling: cell fate control and signal integration in development Science. 284 770 776 10221902 10.1126/science.284.5415.770 1:CAS:528:DyaK1MXivVKrs7Y%3D
10. T Iso Y Hamamori L Kedes 2003 Notch signalling in vascular development Arterioscler Thromb Vasc Biol. 23 543 553 12615665 10.1161/01.ATV.0000060892. 81529.8F 1:CAS:528:DC%2BD3sXisFKgtLo%3D
11. NW Gale MG Dominguez I Noguera L Pan V Hughes DM Valenzuela, et al. 2004 Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development Proc Natl Acad Sci USA. 101 15949 15954 15520367 10.1073/pnas.0407290101 1:CAS:528:DC%2BD2cXhtVGisrfN
12. IB Lobov RA Renard N Papadopoulos NW Gale G Thurston GD Yancopoulos, et al. 2007 Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting Proc Natl Acad Sci USA. 104 3219 3224 17296940 10.1073/pnas.0611206104 1:CAS:528:DC%2BD2sXjtVCntr8%3D
13. M Hellström LK Phng JJ Hofmann E Wallgard L Coultas P Lindblom, et al. 2007 Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis Nature. 445 776 780 17259973 10.1038/nature05571
14. S Suchting C Freitas F le Noble R Benedito C Bréant A Duarte, et al. 2007 The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching Proc Natl Acad Sci USA. 104 3225 3230 17296941 10.1073/pnas.0611177104 1:CAS:528:DC%2BD2sXjtVWlsbg%3D
15. JS Scehnet W Jiang SR Kumar V Krasnoperov A Trindade R Benedito, et al. 2007 Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion Blood. 109 4753 4760 17311993 10.1182/blood-2006-12-063933 1:CAS:528:DC%2BD2sXmt1Ogtbs%3D
16. I Noguera-Troise C Daly NJ Papadopoulos S Coetzee P Boland NW Gale, et al. 2006 Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis Nature. 444 1032 1037 17183313 10.1038/nature05355 1:CAS:528:DC%2BD28XhtlemtLnL
17. T Hoey WC Yen F Axelrod J Basi L Donigian S Dylla, et al. 2009 DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency Cell Stem Cell. 5 168 177 19664991 10.1016/j.stem.2009.05.019 1:CAS:528: DC%2BD1MXhsVCiu77P
18. T Donnem S Andersen K Al-Shibli S Al-Saad LT Busund RM Bremnes 2010 Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival Cancer. 116 5676 5685 20737536 10.1002/cncr.25551
19. AM Jubb EJ Soilleux H Turley G Steers A Parker I Low, et al. 2010 Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer Am J Pathol. 176 2019 2028 20167860 10.2353/ajpath.2010.090908
20. NS Patel MS Dobbie M Rochester G Steers R Poulsom K Le Monnier, et al. 2006 Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer Clin Cancer Res. 12 4836 4844 16914569 10.1158/1078-0432.CCR-06-0285 1:CAS:528:DC%2BD28XotFKgsb8%3D
21. H Oishi M Sunamura S Egawa F Motoi M Unno T Furukawa, et al. 2010 Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer Pancreas. 39 897 903 20182391 10.1097/MPA.0b013e3181ce7185 1:CAS:528:DC%2BC3cXptV2itbw%3D
22. ME Mullendore JB Koorstra YM Li GJ Offerhaus X Fan CM Henderson, et al. 2009 Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer Clin Cancer Res. 15 2291 2301 19258443 10.1158/1078-0432.CCR-08-2004 1:CAS:528:DC%2BD1MXjvVWltbw%3D
23. I Esposito J Kleff F Bergmann C Reiser E Herpel H Friess, et al. 2008 Most pancreatic cancer resections are R1 resections Ann Surg Oncol. 15 1651 1660 18351300 10.1245/s10434-008-9839-8
24. CS Verbeke D Leitch KV Menon MJ McMahon PJ Guillou A Anthoney 2006 Redefining the R1 resection in pancreatic cancer Br J Surg. 93 1232 1237 16804874 10.1002/bjs.5397 1:STN:280:DC%2BD28rntlKnsA%3D%3D
25. Sobin LH, Wittekind CH. International Union Against Cancer. TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss, 2002.
26. X Dong M Javle KR Hess R Shroff JL Abbruzzese D Li 2010 Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer Gastroenterology. 139 464 473 20416304 10.1053/j.gastro.2010.04.042 1:CAS:528:DC%2BC3cXpsVGnu7w%3D
27. TJ Kim YS Lee JH Kang YS Kim CS Kang 2011 Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR J Surg Oncol. 103 46 52 21031415 10.1002/jso.21767
28. J Mattern R Koomagi M Volm 1999 Biological characterization of subgroups of squamous cell lung carcinomas Clin Cancer Res. 5 1459 1463 10389933 1:STN:280:DyaK1Mzhs1Oqtw%3D%3D
29. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd ed. New York: Wiley, 2000.
30. JA Hanley BJ McNeil 1982 The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology. 143 29 36 7063747 1:STN:280:DyaL387ltFyksQ%3D%3D
31. J Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82 4 6 1688381 10.1093/jnci/82.1.4 1:STN:280:DyaK3c%2FnvF2qug%3D%3D
32. S Nagata YF Jin K Yoshizato M Tomoeda M Song N Iizuka, et al. 2009 CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy Ann Surg Oncol. 16 2531 2538 19499276 10.1245/s10434-009- 0532-3
33. P Wang J Fan Z Chen ZQ Meng JM Luo JH Lin, et al. 2009 Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer Ann Surg Oncol. 16 826 835 19165547 10.1245/s10434-008-0284-5